Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants

被引:18
|
作者
Sivolella, Stefano [1 ]
De Biagi, Marleen [1 ,2 ]
Brunello, Giulia [1 ]
Berengo, Mario [1 ]
Pengo, Vittorio [3 ]
机构
[1] Univ Padua, Dept Neurosci, Inst Clin Dent, Via Venezia 90, I-35129 Padua, Italy
[2] Univ Padua, Azienda Osped, Inst Clin Dent, Via Venezia 90, I-35129 Padua, Italy
[3] Padova Univ Hosp, Dept Cardiac Thorac & Vasc Sci, Via Giustiniani 2, I-35128 Padua, Italy
关键词
Dabigatran; Rivaroxaban; Apixaban; Oral anticoagulants; Oral surgery; DIRECT THROMBIN INHIBITOR; DABIGATRAN ETEXILATE; MANAGEMENT; RECOMMENDATIONS; RIVAROXABAN; ANTIDOTE; REVERSAL; WARFARIN; CARE;
D O I
10.1007/s10266-015-0195-4
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The development of new orally administered anticoagulants, such as dabigatran, rivaroxaban, and apixaban, in the past few years has focused on avoiding some of the drawbacks associated with warfarin. This work aims to illustrate the main features of the most commonly used new oral anticoagulants, reviewing the current literature on the management of patients taking these drugs and needing oral and implant surgery, and discussing the currently proposed related guidelines.
引用
收藏
页码:258 / 263
页数:6
相关论文
共 50 条
  • [21] New oral anticoagulants
    Stoberock, K.
    Debus, E. S.
    Larena-Avellaneda, A.
    Kieback, A.
    GEFASSCHIRURGIE, 2013, 18 (07): : 665 - 674
  • [22] New oral anticoagulants
    Galanis, Taki
    Thomson, Lynda
    Palladino, Michael
    Merli, Geno J.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (03) : 310 - 320
  • [23] Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications
    Fulvia Costantinides
    Roberto Rizzo
    Lorenzo Pascazio
    Michele Maglione
    BMC Oral Health, 16
  • [24] Direct Oral Anticoagulants New Drugs and New Concepts
    Levy, Jerrold H.
    Spyropoulos, Alex C.
    Samama, Charles M.
    Douketis, James
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (12) : 1333 - 1351
  • [25] Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation
    Kansal, Anuraag R.
    Zheng, Ying
    Pokora, Tiffany
    Sorensen, Sonja V.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 225 - 237
  • [26] Pharmacology of the new oral anticoagulants
    Dempfle, C. -E.
    HERZ, 2012, 37 (04) : 362 - 368
  • [27] Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL
    Tripodi, Armando
    Di Iorio, Giancarlo
    Lippi, Giuseppe
    Testa, Sophie
    Manotti, Cesare
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (12) : 2137 - 2140
  • [28] Pharmacology of the new target-specific oral anticoagulants
    Cabral, Katherine P.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 36 (02) : 133 - 140
  • [29] New oral anticoagulants from the perspective of trauma surgery
    Siebenlist, S.
    Haas, S.
    Elser, F.
    Stoeckle, U.
    UNFALLCHIRURG, 2010, 113 (11): : 886 - 892
  • [30] Minor oral surgical procedures in patients on oral anticoagulants - a controlled study
    Cannon, PD
    Dharmar, VT
    AUSTRALIAN DENTAL JOURNAL, 2003, 48 (02) : 115 - 118